What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?

Gastroenterology. 2020 Mar;158(4):1175. doi: 10.1053/j.gastro.2019.09.053. Epub 2019 Dec 27.

Authors

Giuseppe Losurdo¹, Alfredo Di Leo¹, Gioacchino Leandro²

Affiliations

¹ Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
² Gastroenterology Unit, National Institute of Gastroenterology, "S. De Bellis" Research Hospital, Castellana Grotte, Italy.

PMID: 31884072
DOI: 10.1053/j.gastro.2019.09.053

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin
Follow-Up Studies
Humans
Lansoprazole
Proton Pump Inhibitors*
Rivaroxaban*

Substances

Proton Pump Inhibitors
Lansoprazole
Rivaroxaban
Aspirin